Transvenous lead extractions in a single high-volume center over a 24-year period: High success rate and low complication rate
- PMID: 37124554
- PMCID: PMC10134393
- DOI: 10.1016/j.hroo.2023.01.003
Transvenous lead extractions in a single high-volume center over a 24-year period: High success rate and low complication rate
Abstract
Background: Transvenous lead extraction (TLE) procedures can be complicated and are associated with a small but significant risk of cardiovascular complications. However, methods and tools vary among centers.
Objective: The purpose of this study was to the present the methods and results of pacemaker and implantable cardioverter-defibrillator TLE procedures in our center over a 24-year period.
Methods: From April 1997 through 2020, we attempted to extract 2964 leads in 1780 procedures and 1642 patients. We mainly utilized single sheath technique using snaring or mechanical rotational sheaths and steel sheaths when necessary. Difficult procedures were performed by an experienced cardiologist, and close supervision was emphasized. Most of the extractions were performed using local anesthesia with sedation.
Results: Median age of patients was 65.0 [interquartile range 20.00] years, and median dwelling time of leads was 5.0 [7.0] years. Clinical success was achieved in 1739 procedures (97.7%) and complete technical success in 2841 leads (95.8%). Clinical success (leaving <4 cm of the lead in the body and achieving the clinical goal for the patient) was achieved for 79 leads (2.7%). TLE failed in 44 leads (1.1%) and 41 procedures (2.3%) among 36 patients (2.2%). There were 23 cases (1.3%) of major complications, with only 1 death directly related to the procedure (<0.1%). In addition, 2 patients with sepsis died within the first 24 hours after the procedure. No caval tears occurred.
Conclusion: Single sheath lead extractions utilizing snaring or mechanical rotational sheaths were effective and safe in our high-volume center as performed by experienced operators.
Keywords: High-volume center; Implantable cardioverter-defibrillator; Pacemaker; Single sheath; Transvenous lead extraction.
© 2023 Heart Rhythm Society. Published by Elsevier Inc.
Figures



Similar articles
-
Performance and outcomes of transvenous rotational lead extraction: Results from a prospective, monitored, international clinical study.Heart Rhythm O2. 2021 Mar 2;2(2):113-121. doi: 10.1016/j.hroo.2021.02.005. eCollection 2021 Apr. Heart Rhythm O2. 2021. PMID: 34113913 Free PMC article.
-
Outcomes of transvenous lead extraction of very old leads using bidirectional rotational mechanical sheaths: Results of a multicentre study.J Cardiovasc Electrophysiol. 2023 Mar;34(3):728-737. doi: 10.1111/jce.15767. Epub 2022 Dec 21. J Cardiovasc Electrophysiol. 2023. PMID: 36477909
-
Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions.Heart Rhythm. 2014 May;11(5):799-805. doi: 10.1016/j.hrthm.2014.01.016. Epub 2014 Jan 17. Heart Rhythm. 2014. PMID: 24444444
-
Pacing and implantable cardioverter-defibrillator transvenous lead extraction.Ital Heart J. 2005 Mar;6(3):261-6. Ital Heart J. 2005. PMID: 15875518 Review.
-
How adequate are the current methods of lead extraction? A review of the efficiency and safety of transvenous lead extraction methods.Europace. 2015 May;17(5):689-700. doi: 10.1093/europace/euu378. Epub 2015 Feb 16. Europace. 2015. PMID: 25687745 Review.
Cited by
-
Endovascular management of internal mammary artery injury during laser-assisted transvenous lead extraction: A rare and life-threatening complication.J Vasc Surg Cases Innov Tech. 2025 Jun 19;11(5):101886. doi: 10.1016/j.jvscit.2025.101886. eCollection 2025 Oct. J Vasc Surg Cases Innov Tech. 2025. PMID: 40799769 Free PMC article. No abstract available.
-
Effective and safe mechanical transvenous lead extraction in a low-volume center.Heart Rhythm O2. 2024 Aug 2;5(9):639-643. doi: 10.1016/j.hroo.2024.07.015. eCollection 2024 Sep. Heart Rhythm O2. 2024. PMID: 39493906 Free PMC article.
References
-
- Mond H.G., Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009—a World Society of Arrhythmia's project. Pacing Clin Electrophysiol. 2011;34:1013–1027. - PubMed
-
- Raatikainen M.J., Arnar D.O., Zeppenfeld K., Merino J.L., Kuck K.H., Hindricks G. Current trends in the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology member countries: 2015 report from the European Heart Rhythm Association. Europace. 2015;17(Suppl 4):72. iv1. - PubMed
-
- Deshmukh A, Patel N, Noseworthy PA, et al. Trends in use and adverse outcomes associated with transvenous lead removal in the United States. Circulation 2015132:2363–2371. - PubMed
-
- Sridhar A.R., Lavu M., Yarlagadda V., et al. Cardiac implantable electronic device-related infection and extraction trends in the U.S. Pacing Clin Electrophysiol. 2017;40:286–293. - PubMed
-
- Wazni O., Wilkoff B.L. Considerations for cardiac device lead extraction. Nat Rev Cardiol. 2016;13:221–229. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous